Search

everythinglearnresearchcommunity

for

Search:↓

Androgen-producing ovarian tumors can cause male-pattern hair loss in women.

Different types of hair loss need specific treatments, and while many classification systems exist, each has its flaws; more research is needed to refine these systems and treatments.

Finasteride, a hair loss drug, may cause long-term sexual side effects due to changes in hormone receptor levels.

Higher testosterone levels can increase the risk of certain diseases like type 2 diabetes in women and prostate cancer in men, but can also protect against autoimmune diseases and hair loss. It also affects body fat and bone density.

Bioengineering can potentially treat hair loss by regenerating hair follicles and cloning hair, but the process is complex and needs more research.

Trichoscopy can diagnose monilethrix, a genetic hair defect causing hair thinning and loss.

The main causes of diffuse hair loss in women are telogen effluvium and androgenetic alopecia, often related to stress and iron deficiency.

Many women with hair loss also have thyroid issues, high blood pressure, and low Vitamin D.

Men with early-onset hair loss have more heart disease risk factors.

Skin problems like acne and excess hair in PCOS are common and linked to being overweight.

Most legal cases about 5α-reductase inhibitors, drugs for hair loss and prostate issues, complain about side effects and delayed cancer diagnosis, with most lawsuits settled out of court.

The document suggests a new way to categorize skin and mind disorders into two main groups to reduce confusion.

Exosome treatment for hair growth is promising but not FDA-approved and needs more research on safety and how it works.

Autism's genetics are linked with early age of puberty and less hair loss, but not with hormone levels or polycystic ovary syndrome.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.

Botulinum toxin injections can help treat common hair loss in men, but more research is needed to confirm this and understand how it works.

Male and female hair loss have different genetic causes.

Female pattern hair loss shows similar characteristics in both genders and should be classified by hair loss patterns, not gender.

Hair growth serums A and C can affect hair growth genes and pathways, suggesting potential for personalized hair loss treatments.

Follicular unit extraction is an effective and minimally invasive treatment for male hair loss.

The belief about hair shedding phases is likely incorrect and needs reevaluation.

Using animal names for skin conditions helps with learning and memory.

Injecting a peptide-hyaluronic acid mix improved hair growth in men with hair loss and was safe.

Hormone replacement therapy may improve hair growth in the frontal hairline of postmenopausal women with hair loss.

The research suggests immune system changes and specific gene expression may contribute to male hair loss, proposing potential new treatments.

Rare genetic variants in five specific genes are linked to male-pattern hair loss but only account for a small part of the risk.

Hair loss (androgenetic alopecia) mildly to moderately affects men's quality of life but not significantly their mental health.

Practitioners treating hair loss need better education and resources to overcome challenges like commercial bias and ethical dilemmas.

The conclusion is that recognizing the difference between gender identity and biological sex is crucial in dermatology to improve patient care and research accuracy.

Most men using teledermatology for hair loss treatment saw improved hair and self-esteem, with some experiencing side effects.